Items where Author is "Reubi, J. C."

2010

Cordier, D. and Forrer, F. and Bruchertseifer, F. and Morgenstern, A. and Apostolidis, C. and Good, S. and Müller-Brand, J. and Mäcke, H. and Reubi, J. C. and Merlo, A.. (2010) Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P : a pilot trial. European journal of nuclear medicine and molecular imaging, Vol. 37, H. 7. pp. 1335-1344.

2008

Cescato, R. and Erchegyi, J. and Waser, B. and Piccand, V. and Maecke, H. R. and Rivier, J. E. and Reubi, J. C.. (2008) Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting. Journal of Medicinal Chemistry, Vol. 51, H. 13. pp. 4030-4037.

Wild, D. and Mäcke, H. and Christ, E. and Gloor, B. and Reubi, J. C.. (2008) Glucagon-like peptide 1-receptor scans to localize occult insulinomas. The New England journal of medicine, Vol. 359, H. 7. pp. 766-768.

Heppeler, A. and André, J. P. and Buschmann, I. and Wang, X. and Reubi, J. C. and Hennig, M. and Kaden, T. A. and Maecke, H. R.. (2008) Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting. Chemistry, a European journal, Vol. 14, H. 10. pp. 3026-3034.

Ginj, M. and Zhang, H. and Eisenwiener, K. P. and Wild, D. and Schulz, S. and Rink, H. and Cescato, R. and Reubi, J. C. and Maecke, H. R.. (2008) New pansomatostatin ligands and their chelated versions : affinity profile, agonist activity, internalization, and tumor targeting. Clinical cancer research, Vol. 14. pp. 2019-2027.

Reubi, J. C. and Maecke, H. R.. (2008) Peptide-based probes for cancer imaging. Journal of nuclear medicine, Vol. 49, H. 11. pp. 1735-1738.